These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8837915)

  • 1. Negative symptoms, neurological signs and neuropsychological impairments in 204 Hong Kong Chinese patients with schizophrenia.
    Chen EY; Lam LC; Chen RY; Nguyen DG
    Br J Psychiatry; 1996 Feb; 168(2):227-33. PubMed ID: 8837915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential relationships between positive and negative symptoms and neuropsychological deficits in schizophrenia.
    Berman I; Viegner B; Merson A; Allan E; Pappas D; Green AI
    Schizophr Res; 1997 May; 25(1):1-10. PubMed ID: 9176922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symptomatic remission and cognitive impairment in first-episode schizophrenia: a prospective 3-year follow-up study.
    Chang WC; Ming Hui CL; Yan Wong GH; Wa Chan SK; Ming Lee EH; Hai Chen EY
    J Clin Psychiatry; 2013 Nov; 74(11):e1046-53. PubMed ID: 24330905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurological soft signs and neuropsychological performance in patients with first episode schizophrenia.
    Mohr F; Hubmann W; Albus M; Franz U; Hecht S; Scherer J; Binder J; Sobizack N
    Psychiatry Res; 2003 Nov; 121(1):21-30. PubMed ID: 14572621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficit in schizophrenia: the relationship between negative symptoms and neurocognition.
    Penadés R; Gastó C; Boget T; Catalán R; Salamero M
    Compr Psychiatry; 2001; 42(1):64-9. PubMed ID: 11154718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of soft neurological signs in positive and negative subtype of schizophrenia.
    Cvetić T; Vuković O; Britvić D; Ivković M; Dukić-Dejanović S; Lecić-Tosevski D
    Psychiatr Danub; 2009 Jun; 21(2):174-8. PubMed ID: 19556945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relations between neuropsychological vulnerability markers and negative symptoms in schizophrenia.
    Suslow T; Junghanns K; Weitzsch C; Arolt V
    Psychopathology; 1998; 31(4):178-87. PubMed ID: 9697161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Schedule for evaluation of the deficit syndrome in schizophrenia: Schedule for Deficit Syndrome (SDS) (Kirkpatrick et al.). Importance pertinence of the SDS. Introduction of the French version].
    Ribeyre JM; Dollfus S; Lesieur P; Ménard JF; Petit M
    Encephale; 1994; 20(4):413-9. PubMed ID: 7988405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors, pre-morbid functioning and episode correlates of neurological soft signs in drug-naive patients with schizophrenia-spectrum disorders.
    Peralta V; de Jalón EG; Campos MS; Basterra V; Sanchez-Torres A; Cuesta MJ
    Psychol Med; 2011 Jun; 41(6):1279-89. PubMed ID: 20860873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of negative symptoms with tardive dyskinesia in schizophrenic patients.
    Chiu H; Lau J; Lam L; Shum P
    Aust N Z J Psychiatry; 1993 Jun; 27(2):228-32. PubMed ID: 8103320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Motoric neurological soft signs and psychopathological symptoms in schizophrenic psychoses.
    Jahn T; Hubmann W; Karr M; Mohr F; Schlenker R; Heidenreich T; Cohen R; Schröder J
    Psychiatry Res; 2006 Jun; 142(2-3):191-9. PubMed ID: 16650902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reliability and validity of the Chinese versions of the Scales for Assessment of Positive and Negative Symptoms.
    Phillips MR; Xiong W; Wang RW; Gao YH; Wang XQ; Zhang NP
    Acta Psychiatr Scand; 1991 Oct; 84(4):364-70. PubMed ID: 1746289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scales for evaluating depressive symptoms in Chinese patients with schizophrenia.
    Liu H; Zhang H; Xiao W; Liu Q; Fu P; Chen J; Wang G; Yang F; Wang G; Wang X; Li L
    J Nerv Ment Dis; 2009 Feb; 197(2):140-2. PubMed ID: 19214051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hypofrontality and negative symptoms in schizophrenia: synthesis of anatomic and neuropsychological knowledge and ecological perspectives].
    Semkovska M; Bédard MA; Stip E
    Encephale; 2001; 27(5):405-15. PubMed ID: 11760690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychometric properties of the positive and negative syndrome scale (PANSS) in schizophrenia.
    Peralta V; Cuesta MJ
    Psychiatry Res; 1994 Jul; 53(1):31-40. PubMed ID: 7991730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humor appreciation deficit in schizophrenia: the relevance of basic neurocognitive functioning.
    Bozikas VP; Kosmidis MH; Giannakou M; Anezoulaki D; Petrikis P; Fokas K; Karavatos A
    J Nerv Ment Dis; 2007 Apr; 195(4):325-31. PubMed ID: 17435483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schizophrenic syndrome and Wisconsin Card Sorting Test dimensions.
    Cuesta MJ; Peralta V; Caro F; de Leon J
    Psychiatry Res; 1995 Sep; 58(1):45-51. PubMed ID: 8539311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Convergent validity and neuropsychological correlates of the schedule for the assessment of negative symptoms (SANS) attention subscale.
    Vadhan NP; Serper MR; Harvey PD; Chou JC; Cancro R
    J Nerv Ment Dis; 2001 Sep; 189(9):637-41. PubMed ID: 11580009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical symptom dimensions and deficits on the Continuous Performance Test in schizophrenia.
    Liu SK; Hwu HG; Chen WJ
    Schizophr Res; 1997 Jun; 25(3):211-9. PubMed ID: 9264176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.